Advisors Capital Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-49,492
| Closed | -$8.77M | – | 320 |
|
|
2020
Q1 | $8.77M | Sell |
49,492
-68,595
| -58% | -$12.9M | 0.56% | 60 |
|
|
2019
Q4 | $22.6M | Buy |
118,087
+181
| +0.2% | +$32.7K | 1.05% | 25 |
|
|
2019
Q3 | $19.8M | Buy |
117,906
+5,876
| +5% | +$957K | 1.08% | 25 |
|
|
2019
Q2 | $18.8M | Buy |
112,030
+14,096
| +14% | +$1.95M | 1.11% | 22 |
|
|
2019
Q1 | $14.5M | Buy |
97,934
+19,161
| +24% | +$2.78M | 0.9% | 43 |
|
|
2018
Q4 | $10.5M | Sell |
78,773
-366
| -0.5% | -$60K | 0.77% | 52 |
|
|
2018
Q3 | $15.1M | Buy |
79,139
+2,150
| +3% | +$395K | 0.99% | 36 |
|
|
2018
Q2 | $12.8M | Sell |
76,989
-41,871
| -35% | -$6.72M | 0.88% | 47 |
|
|
2018
Q1 | $20M | Buy |
+118,860
| New | +$19.9M | 1.51% | 12 |
|
|
2017
Q4 | – | Sell |
-10,970
| Closed | -$2.25M | – | 200 |
|
|
2017
Q3 | $2.25M | Buy |
10,970
+1,041
| +10% | +$242K | 0.18% | 133 |
|
|
2017
Q2 | $2.41M | Buy |
9,929
+973
| +11% | +$229K | 0.2% | 127 |
|
|
2017
Q1 | $2.14M | Buy |
+8,956
| New | +$2.09M | 0.18% | 129 |
|
|
2016
Q4 | – | Sell |
-8,507
| Closed | -$1.96M | – | 183 |
|
|
2016
Q3 | $1.96M | Sell |
8,507
-7,068
| -45% | -$1.73M | 0.19% | 134 |
|
|
2016
Q2 | $3.6M | Sell |
15,575
-1,459
| -9% | -$336K | 0.37% | 85 |
|
|
2016
Q1 | $4.57M | Buy |
17,034
+60
| +0.4% | +$17.2K | 0.46% | 74 |
|
|
2015
Q4 | $5.3M | Buy |
16,974
+301
| +2% | +$89.6K | 0.53% | 64 |
|
|
2015
Q3 | $4.53M | Buy |
16,673
+98
| +0.6% | +$30.1K | 0.5% | 71 |
|
|
2015
Q2 | $5.03M | Sell |
16,575
-264
| -2% | -$78.7K | 0.55% | 70 |
|
|
2015
Q1 | $5.01M | Buy |
16,839
+639
| +4% | +$182K | 0.56% | 65 |
|
|
2014
Q4 | $4.17M | Buy |
16,200
+473
| +3% | +$118K | 0.51% | 74 |
|
|
2014
Q3 | $3.79M | Sell |
15,727
-2,009
| -11% | -$450K | 0.49% | 83 |
|
|
2014
Q2 | $3.96M | Buy |
17,736
+3,532
| +25% | +$731K | 0.53% | 74 |
|
|
2014
Q1 | $2.92M | Buy |
14,204
+5,269
| +59% | +$1.04M | 0.45% | 82 |
|
|
2013
Q4 | $1.5M | Sell |
8,935
-1,151
| -11% | -$180K | 0.25% | 106 |
|
|
2013
Q3 | $1.45M | Buy |
10,086
+506
| +5% | +$67.4K | 0.3% | 97 |
|
|
2013
Q2 | $1.21M | Buy |
+9,580
| New | +$1.08M | 0.27% | 99 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Advisors Capital Management's AGN Position: Q2 2020 in Review
Advisors Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 49,492 shares — an estimated $8.77M sold.
Advisors Capital Management first reported a position in AGN in Q2 2013 and held it in 26 quarters. The position peaked at $22.6M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Advisors Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Advisors Capital Management sold 49,492 Allergan plc shares in Q2 2020, an estimated $8.77M.
- Advisors Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 26 quarters.
- Advisors Capital Management's Allergan plc position peaked at $22.6M in Q4 2019.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Advisors Capital Management's 13F filing for Q2 2020, filed 18 Aug 2020.